| 1242 |
Centers for Disease Control and Prevention |
Html |
en |
Pedestrian Traffic Deaths Among Residents, Visitors, andHomeless Persons - Clark County, Nevada, 2008-2011 |
Kaci L. Hickox, MSN, MPH1,2, Nancy Williams, MD2, Laurie F. Beck, MPH3, Tom Coleman, MD2, John Fudenberg4, Byron Robinson, PhD5, John Middaugh, MD2 (Author affiliations at end of text). |
| Kaci L. Hickox | 0.429115 |
| death certificate data | 0.548114 |
| Las Vegas Boulevard | 0.418314 |
| state census data | 0.379149 |
| homeless pedestrians | 0.412446 |
| visitor pedestrian deaths | 0.569145 |
| pedestrian behavior | 0.438084 |
| pedestrian blood alcohol | 0.502157 |
| pedestrian traffic death | 0.528652 |
| homeless shelter curfews | 0.416493 |
| motor vehicle collisions | 0.540631 |
| Las Vegas | 0.478476 |
| homeless decedent | 0.390515 |
| Homeless pedestrian death | 0.567747 |
| pedestrian death rates | 0.844848 |
| higher pedestrian death | 0.487981 |
| homeless pedestrian deaths | 0.619278 |
| injury deaths | 0.391177 |
| visitors | 0.401619 |
| Clark County residents | 0.410846 |
| homeless persons | 0.932153 |
| Nevada residents | 0.376912 |
| Southern Nevada Health | 0.377119 |
| higher death rates | 0.389497 |
| residents | 0.427677 |
|
| pedestrian deaths | 0.897101 |
| homeless census surveys | 0.475074 |
| pedestrian alcohol impairment | 0.465261 |
| Clark County Office | 0.401399 |
| pedestrian signals | 0.433088 |
| resident pedestrian death | 0.548081 |
| greater pedestrian traffic | 0.493273 |
| Nevada Health District | 0.42467 |
| unsheltered homeless population | 0.421139 |
| collision sites | 0.455687 |
| pedestrian refuge islands | 0.457512 |
| Clark County death | 0.419067 |
| Homeless service providers | 0.412977 |
| motor vehicle deaths | 0.432863 |
| homeless census survey | 0.432102 |
| group–specific death rates | 0.396379 |
| Clark County | 0.83031 |
| office data | 0.465251 |
| death certificate race/ethnicity | 0.38408 |
| pedestrian exposure | 0.433699 |
| pedestrian traffic deaths | 0.654768 |
| unsheltered homeless persons | 0.477833 |
| Annual resident pedestrian | 0.483165 |
| visitor pedestrian death | 0.480701 |
|
CLICK HERE |
| 5426 |
Centers for Disease Control and Prevention |
Html |
en |
WARNING: Cigarettes cause cancer. |
null |
| right web address | 0.987879 |
| Español | 0.403508 |
| Language Assistance | 0.712207 |
| Português | 0.391584 |
| Kreyòl Ayisyen | 0.700648 |
| Instructions | 0.282468 |
| different file formats | 0.919531 |
| Tiếng Việt | 0.70734 |
| Deutsch | 0.348548 |
| help | 0.283342 |
|
| РуÑ?Ñ?кий | 0.283258 |
| Polski | 0.39029 |
| Tagalog | 0.362008 |
| options | 0.298124 |
| Français | 0.385004 |
| Downloading Viewers | 0.795919 |
| العربية | 0.436655 |
| information | 0.283148 |
| page | 0.385868 |
|
CLICK HERE |
| 6116 |
Centers for Disease Control and Prevention |
Html |
en |
Silica - crystalline (as respirable dust) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6845 |
Centers for Disease Control and Prevention |
Html |
en |
CDC - Preventing Chronic Disease: Volume 9, 2012: 11_0196 |
Public access defibrillation (PAD) policies have been enacted to create programs that increase the public availability of these devices. The objective of this study was to describe each state’s legal requirements for recommended PAD program elements. |
| PAD program elements | 0.737354 |
| common PAD element | 0.32298 |
| PAD programs | 0.867593 |
| out-of-hospital cardiac arrest | 0.552995 |
| state PAD laws | 0.374526 |
| survival rates | 0.315862 |
| comprehensive PAD | 0.353366 |
| PAD program facilitators | 0.354551 |
| emergency response plan | 0.296881 |
| common PAD elements | 0.350526 |
| AED placement | 0.332958 |
| targeted AED placement | 0.316938 |
| quality improvement | 0.356667 |
| extent PAD policies | 0.319532 |
| civil immunity | 0.325044 |
| jurisdictions | 0.503555 |
| additional PAD elements | 0.339675 |
| PAD medical directors | 0.324463 |
| AED | 0.51896 |
| PAD elements | 0.476901 |
| sudden cardiac arrest | 0.303638 |
| emergency response | 0.348718 |
| PAD program facilitator | 0.367992 |
| cardiac arrest | 0.906151 |
|
| American Heart Association | 0.460722 |
| comprehensive PAD legislation | 0.307576 |
| fewer PAD elements | 0.349377 |
| PAD maintenance | 0.32594 |
| public access defibrillation | 0.611637 |
| PAD program element | 0.345998 |
| existing PAD programs | 0.33919 |
| medical emergency response | 0.306084 |
| AED device | 0.317124 |
| AEDs | 0.375556 |
| external defibrillator | 0.350481 |
| cardiac arrest survival | 0.337233 |
| AED sites | 0.337613 |
| effective PAD policies | 0.401237 |
| emergency medical service | 0.309832 |
| select AED sites | 0.314109 |
| recommended PAD program | 0.489388 |
| PAD policies | 0.50489 |
| rescuer PAD programs | 0.422643 |
| comprehensive PAD policies | 0.348451 |
| continuous quality improvement | 0.338198 |
| comprehensive PAD policy | 0.332778 |
| mandatory PAD registries | 0.389743 |
| AED users | 0.337134 |
|
CLICK HERE |
| 7275 |
Centers for Disease Control and Prevention |
Html |
en |
Infant Lead Poisoning Associated with Use of Tiro, an Eye Cosmetic from Nigeria - Boston, Massachusetts, 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| Infantile lead poisoning | 0.571574 |
| Environmental Health Svcs | 0.518789 |
| lead hazards | 0.519678 |
| venous BLL | 0.574095 |
| visual development | 0.55728 |
| Nigerian tiro container | 0.696462 |
| potential lead exposure | 0.579584 |
| Disease Control | 0.533026 |
| children | 0.545374 |
| elevated blood lead | 0.660262 |
| P. Lead poisoning | 0.57483 |
| lead sulfide | 0.632113 |
| nonpaint lead sources | 0.650145 |
| tiro eye | 0.619077 |
| elevated BLLs | 0.597557 |
| relatively low bioavailability | 0.574675 |
| Environmental Health Specialty | 0.608555 |
| tiro powder | 0.624155 |
| lead poisoning | 0.925168 |
| blood lead testing | 0.604707 |
| U.S. Geological Survey | 0.568738 |
| take-home exposure | 0.517992 |
| lead exposure | 0.744994 |
| certain immigrant populations | 0.849896 |
|
| fatal childhood lead | 0.543914 |
| similar products | 0.584501 |
| lead poisoning cases | 0.647333 |
| male infant | 0.57643 |
| tiro | 0.887535 |
| Nigerian descent | 0.522913 |
| United States | 0.665214 |
| Pediatric Environmental Health | 0.602599 |
| confirmatory venous BLL | 0.535345 |
| Middle East | 0.594428 |
| adverse health effects | 0.518426 |
| Boston Children | 0.52301 |
| public health | 0.702834 |
| Health Specialty Unit | 0.609068 |
| public health workers | 0.594384 |
| eye cosmetic powder | 0.548862 |
| eyelids | 0.521425 |
| Nigerian eye cosmetic | 0.526955 |
| blood lead level | 0.651087 |
| significant lead exposure | 0.577997 |
| Nigeria Centre | 0.534935 |
| childhood lead poisoning | 0.637301 |
| lead-poisoned child | 0.554703 |
| PEHSU staff members | 0.521458 |
|
CLICK HERE |
| 7509 |
Centers for Disease Control and Prevention |
Html |
en |
Perchlorate Fact Sheet October 5, 2006 |
Data Resources for the National Center for Environmental Health |
| thyroid hormone | 0.84512 |
| micrograms | 0.435435 |
| thyroid hormone lead | 0.683566 |
| thyroid hormone levels | 0.75181 |
| body’s metabolism | 0.493597 |
| thyroid stimulating hormone | 0.703655 |
| good source | 0.48783 |
| perchlorate exposure | 0.85389 |
| human activity | 0.485713 |
| widespread presence | 0.483762 |
| Perchlorate Ingestion | 0.811389 |
| small-to-moderate size changes | 0.582611 |
| previous studies | 0.50412 |
| statistically significant association | 0.570335 |
| U.S. Food | 0.480177 |
| perchlorate | 0.998751 |
| journal Environmental Health | 0.566812 |
| iodized salt | 0.50291 |
| lower iodine levels | 0.829021 |
| TSH levels | 0.520416 |
| thyroid function | 0.756905 |
| chemical | 0.430922 |
| urine iodine levels | 0.80417 |
| Environmental Protection Agency | 0.552412 |
| similar association | 0.495401 |
|
| health effects | 0.487463 |
| women | 0.554648 |
| thyroxine levels | 0.535481 |
| study | 0.512983 |
| good thyroid health | 0.654237 |
| United States | 0.494138 |
| thyroid gland | 0.644398 |
| Drug Administration | 0.483372 |
| natural sources | 0.483737 |
| sufficient intake | 0.494159 |
| lower iodine intake | 0.738196 |
| Health Implications | 0.484683 |
| dietary iodine | 0.627862 |
| relationship | 0.451719 |
| low-dose exposure | 0.496004 |
| People | 0.430798 |
| CDC researchers | 0.505069 |
| U.S. population | 0.500339 |
| teaspoon | 0.421173 |
| µg/L). | 0.505234 |
| higher levels | 0.507707 |
| Perchlorate Questions | 0.79626 |
| thyroid hormones | 0.586227 |
| rocket fuel | 0.484995 |
|
CLICK HERE |
| 9908 |
Centers for Disease Control and Prevention |
Html |
en |
What Is Prostate Cancer? |
Cancer is a disease in which cells in the body grow out of control. When cancer starts in the prostate, it is called prostate cancer. |
| American men | 0.413689 |
| testicles | 0.274394 |
| semen | 0.254556 |
| skin cancer | 0.394752 |
| disease | 0.25078 |
| control | 0.25046 |
| prostate changes | 0.64064 |
| urethra | 0.360977 |
| body | 0.250588 |
| walnut | 0.252513 |
|
| prostate cancer | 0.770672 |
| common cancer | 0.393753 |
| cells | 0.256124 |
| urine flow | 0.438307 |
| size | 0.287949 |
| bladder | 0.335982 |
| man ages | 0.408501 |
| prostate | 0.935326 |
| rectum | 0.274527 |
| penis | 0.266149 |
|
CLICK HERE |
| 10623 |
Centers for Disease Control and Prevention |
Html |
en |
Creating the Model Aquatic Health Code (MAHC) | Model Aquatic Health Code |
null |
| Model Aquatic Health | 0.811986 |
| CDC Page Moved | 0.920246 |
|
|
CLICK HERE |
| 11209 |
Centers for Disease Control and Prevention |
Html |
es |
10 años de educación einvestigaciones sobre el síndrome de Tourette |
El Mes de Concientización sobre el Síndrome de Gilles de la Tourette es del 15 de mayo al 15 de junio. Infórmese más sobre el trabajo de una década de los CDC en que realizan investigaciones y educan al público sobre este síndrome |
|
|
CLICK HERE |
| 14087 |
Centers for Disease Control and Prevention |
Html |
en |
CDC Guideline for Prescribing Opioids for Chronic Pain |
null |
| patient-centered clinical practices | 0.618226 |
| specific recommendations | 0.529171 |
| chronic pain | 0.956601 |
| access | 0.445824 |
| abuse | 0.423454 |
| death | 0.420962 |
| previous guidelines | 0.577038 |
| recommendations | 0.538911 |
| palliative care | 0.522152 |
| CDC Guideline | 0.847976 |
| Higher doses | 0.523247 |
| number | 0.423499 |
| Prescribing Opioids | 0.748205 |
| thorough assessments | 0.514405 |
| harms | 0.42362 |
| prescription opioids | 0.721121 |
| high risk patients | 0.604782 |
| monitoring programs | 0.50897 |
| chronic pain treatment | 0.871437 |
| morphine milligram equivalents | 0.626399 |
| effective chronic pain | 0.879489 |
| higher risk | 0.512069 |
|
| possible treatments | 0.517125 |
| relatively low doses | 0.619428 |
| dosage recommendations | 0.533729 |
| normal tissue | 0.520023 |
| available tools | 0.509996 |
| primary care settings | 0.636847 |
| active cancer treatment | 0.621605 |
| people | 0.423484 |
| way opioids | 0.861295 |
| pose risk | 0.514303 |
| opioid pain medication | 0.749572 |
| opioid use disorder | 0.687616 |
| clinical practice guidelines | 0.833487 |
| state prescription drug | 0.60825 |
| opioid prescribing guidelines | 0.668338 |
| risks | 0.443416 |
| main focus areas | 0.607812 |
| recent technological advances | 0.60256 |
| safety precautions | 0.512206 |
| time | 0.421505 |
| opioids | 0.953348 |
| end-of-life care | 0.525262 |
|
CLICK HERE |